Overview

A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes

Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study is therefore to investigate the efficacy of the PEG-formulation to reduce the frequency and duration of genital herpes recurrences, to assess its safety and tolerability and to investigate its effect on shedding.
Phase:
Phase 2
Details
Lead Sponsor:
Devirex AG